Mytide Therapeutics

About:

Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.

Website: https://www.mytide.io

Twitter/X: mytidetx

Top Investors: National Science Foundation, Alloy Therapeutics, Creative Destruction Lab (CDL), Massachusetts Life Sciences Center, Uncommon Denominator

Description:

Mytide is committed to providing peptides to serve a diverse array of applications. They intend to work closely with partners to overcome challenges in synthesizing and purifying particular classes of peptides of interest, identify useful peptide modifications, and design and construct peptide libraries. They provide initial partners access to their cloud platform for immediate ordering, properties calculator, order tracking, and interactive data display.

Total Funding Amount:

$7.47M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

hello(AT)mytide.io

Founders:

Dale Thomas, Jason Norris

Number of Employees:

1-10

Last Funding Date:

2022-03-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai